Evernow Raises $28.5M in Series A Funding

Evernow Logo

Evernow, a San Francisco, CA-based telehealth company dedicated to using science to transform care for women in perimenopause and menopause, raised $28.5M in Series A funding.

The round was led by NEA with participation from 8VC, Refactor Capital, Coelius Capital, and other institutional investors as well as notable angel investors Gwyneth Paltrow, Glennon Doyle, Abby Wambach, Carla Harris (recent Vice Chairman and Managing Director at Morgan Stanley), Gwynne Shotwell, Sheila Lirio Marcelo (NEA Venture Partner and founder of Care.com and ProofofLearn), Drew Barrymore, and Cameron Diaz.

The company intends to use the funds for expanding the team, building member community, and leveraging data and research to focus on product development.

Led by Alicia Jackson, PhD, CEO, Evernow is a telehealth company using science to provide women with perimenopause and menopause care. The system is using technology to match women with tailored prescription treatments and expert clinicians for ongoing virtual support through a user-friendly interface. The company delivers targeted healthcare that addresses not only the near-term, but also the long-term symptoms that result from the critical hormone drops that start in perimenopause and extend through menopause and beyond.

Since its founding in 2019, Evernow has studied more than 100,000 women experiencing perimenopause and menopause symptoms.

This news follows the hire of Chief Medical Officer Leah Millheiser, MD, NCMP, a Stanford professor and expert in menopause and female sexual medicine; Allie Sharma, MD, MSc, a Weill Cornell-trained psychiatrist with a deep background in both private practice and population health; and the Buck Institute’s Jennifer Garrison, PhD, a leading authority on ovarian biology and expert on reproductive lifespan.